TCM Limited Reports Q3 FY26 Financial Results with Revenue Decline
TCM Limited reported Q3 FY26 results showing revenue decline across operations. Standalone revenue fell to ₹520.15 lakhs from ₹588.79 lakhs in Q3 FY25, while consolidated revenue dropped to ₹568.74 lakhs from ₹617.98 lakhs. The company posted standalone net loss of ₹56.21 lakhs and consolidated net loss of ₹117.64 lakhs. For nine months FY26, losses widened significantly with standalone loss at ₹235.39 lakhs and consolidated loss at ₹436.06 lakhs. The company is pursuing acquisition of Better Feeds Private Limited for ₹765 lakhs consideration.

*this image is generated using AI for illustrative purposes only.
TCM Limited announced its financial results for the third quarter of FY26 ended 31st December 2025, showing revenue decline across both standalone and consolidated operations. The company, engaged in trading, manufacturing, educational services, and real estate development, faced challenging market conditions during the quarter.
Standalone Financial Performance
The company's standalone operations showed mixed results for Q3 FY26. Revenue from operations declined to ₹520.15 lakhs compared to ₹588.79 lakhs in Q3 FY25, representing a significant decrease.
| Metric | Q3 FY26 | Q3 FY25 | Nine Months FY26 | Nine Months FY25 |
|---|---|---|---|---|
| Revenue from Operations | ₹520.15 lakhs | ₹588.79 lakhs | ₹1,326.53 lakhs | ₹1,744.85 lakhs |
| Other Income | ₹17.64 lakhs | ₹12.16 lakhs | ₹100.78 lakhs | ₹40.50 lakhs |
| Total Income | ₹537.79 lakhs | ₹600.95 lakhs | ₹1,427.31 lakhs | ₹1,785.35 lakhs |
| Net Loss | ₹(56.21) lakhs | ₹(52.74) lakhs | ₹(235.39) lakhs | ₹(115.67) lakhs |
| Earnings Per Share | ₹(0.75) | ₹(0.71) | ₹(3.15) | ₹(1.55) |
The company reported a net loss of ₹56.21 lakhs for Q3 FY26 compared to ₹52.74 lakhs loss in the corresponding quarter of the previous year. For the nine-month period, the net loss widened significantly to ₹235.39 lakhs from ₹115.67 lakhs in the previous year.
Consolidated Financial Results
On a consolidated basis, which includes subsidiaries iSpark Learning Solutions Private Limited, TCM Healthcare Private Limited, TCM Properties Private Limited, and TCM Solar Private Limited, the performance showed similar trends.
| Parameter | Q3 FY26 | Q3 FY25 | Nine Months FY26 | Nine Months FY25 |
|---|---|---|---|---|
| Consolidated Revenue | ₹568.74 lakhs | ₹617.98 lakhs | ₹1,481.78 lakhs | ₹1,835.63 lakhs |
| Consolidated Net Loss | ₹(117.64) lakhs | ₹(90.25) lakhs | ₹(436.06) lakhs | ₹(262.66) lakhs |
| Consolidated EPS | ₹(1.53) | ₹(1.16) | ₹(5.57) | ₹(3.23) |
The consolidated net loss for Q3 FY26 was ₹117.64 lakhs compared to ₹90.25 lakhs in Q3 FY25, indicating deteriorating performance across the group.
Segment-wise Performance Analysis
The company operates across four main business segments with varying performance levels during the quarter.
Trading Segment
The trading segment, dealing in solar, healthcare, autocare, and audio products, showed improved revenue of ₹239.97 lakhs in Q3 FY26 compared to ₹106.41 lakhs in Q3 FY25. However, segment results declined to ₹6.34 lakhs from ₹2.24 lakhs.
Manufacturing Operations
The manufacturing segment reported revenue of ₹245.61 lakhs in Q3 FY26 versus ₹272.09 lakhs in Q3 FY25. The segment posted a loss of ₹16.28 lakhs compared to a profit of ₹16.24 lakhs in the previous year quarter.
Real Estate Development
Real estate operations generated revenue of ₹30.25 lakhs in Q3 FY26, significantly lower than ₹210.29 lakhs in Q3 FY25. Despite the revenue decline, segment results remained positive at ₹4.45 lakhs compared to ₹19.82 lakhs in the previous year.
Educational Services
The educational segment, operated through subsidiary iSpark Learning Solutions, reported revenue of ₹52.91 lakhs in Q3 FY26 compared to ₹29.19 lakhs in Q3 FY25. However, the segment continued to post losses of ₹7.69 lakhs.
Strategic Developments
TCM Limited has entered into a binding memorandum of understanding to acquire 100% shareholding in Better Feeds Private Limited for a consideration of ₹765 lakhs. As of 31st December 2025, the company has paid an advance of ₹108.23 lakhs towards this proposed acquisition, subject to due diligence, regulatory approvals, and execution of a definitive Share Purchase Agreement.
The company maintains its paid-up equity share capital at ₹747.79 lakhs with face value of ₹10 per share. The financial results were approved by the Board of Directors in their meeting held on 13th February 2026.
Historical Stock Returns for TCM
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.32% | +2.42% | -10.17% | +37.09% | +25.83% | +124.48% |




























